MHRA asks for views on proposed guidance to support the safe regulation of new personalised cancer therapies

  • Post author:
  • Post category:

The Medicines and Healthcare products Regulatory Agency (MHRA) has today launched a consultation on regulatory guidance for individualised mRNA cancer immunotherapies (colloquially referred to as cancer vaccines). This is an…

Continue ReadingMHRA asks for views on proposed guidance to support the safe regulation of new personalised cancer therapies

UK patients enabled access to transformative new medicines in shortest time possible via new, integrated Innovative Licensing and Access Pathway

  • Post author:
  • Post category:

Full details have been published today of the refreshed UK-wide Innovative Licensing and Access Pathway (ILAP), that will offer a clearer, more streamlined and integrated process for developers to help…

Continue ReadingUK patients enabled access to transformative new medicines in shortest time possible via new, integrated Innovative Licensing and Access Pathway